Načítá se...
New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is typically diagnosed at an advanced stage with systemic therapy being the mainstay of treatment. Survival continues to be limited, typically less than one year. The PDAC microenvironment is characterized by a paucity of malignant epithelial cells, abundant s...
Uloženo v:
| Vydáno v: | Drugs |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7466866/ https://ncbi.nlm.nih.gov/pubmed/32306207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-020-01304-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|